News

23.01.12

A modified version of our original FEP Photochemical Flow Reactor (DOI) has been used by Seeberger & Levesque in a stunning continuous-flow synthesis of the front-line anti-malaria drug Artemisinin (DOI). As reported the complete integrated flow system can synthesize more the 200 g per day of this life saving drug and 400 such reactor systems could provide the current world's supply of Artemisinin required to treat the disease.

02.12.11

Congratulations go to Katie Maskill for recently securing project alignment with AstraZeneca in her PhD project on pyrrole photochemistry.

03.10.11

Congratulations go to Dr Kara Cubbage for recently passing her PhD viva with no corrections!